Not Yet RecruitingPhase 1

Clinical and Laboratory Evaluation of Antifungal Resistance in Tinea Capitis

30 participantsStarted 2024-05

Plain-language summary

AIM OF WORK : 1. Detect the most common fungal strains that cause tinea capitis 2. Detect Different effectiveness of terbinafine in different cases 3. Detect the resistant strains. 4. Detect the mycological and the clinical cure rates upon using systemic terbinafine in treatment of tinea capitis

Who can participate

Age range4 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients from both sexes aged \> 4 years old. * patients have tinea capitis (scaly type) Exclusion Criteria: * Patients have other types of tinea capitis infection. * Patients with heart valve diseases , Hearing loss , liver or kidney diseases. * Pregnant or lactating females. * Personal or family history of malignancy. * Immunocompramised patients.

What they're measuring

-Detect the most common Fungal strains that cause tinea capitis

Timeframe: Baseline

Resistant strain in tinea capitis

Timeframe: Baseline

Trial details

NCT IDNCT06400056

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-04

Contact for this trial

Reem Atef Ibrahim, M,B,B,CH

01097654229 reematef1993@gmail.com

View on ClinicalTrials.gov More Fungal Resistance trials